ABSTRACT
This retrospective observational online study was carried out to evaluate the effect of the COVID-19 pandemic and its related lockdown on female sexual functions and reproductive health. It included 409 sexually active females. The sexual function was assessed using the Female Sexual Function Index (FSFI). The reproductive life was assessed by a structured self-administered questionnaire modified from Egypt Demographic and Health Survey. The study revealed a significant decrease in the overall FSFI score during the pandemic lockdown compared to the pre-pandemic score (19.3 ± 6 vs. 21.3 ± 6.4, P<0.001). Below half (41.6 %) of women were using contraception methods during the pandemic, while 27.9% had stopped taking contraception during the pandemic, 30.6% (57/186) of the pregnant women only tended to get pregnant. So, the COVID-19 pandemic and its related lockdown were associated with an elevated risk for female sexual dysfunction and altered women's reproductive health quality. Heath system should therefore develop new methods to provide basic reproductive health service, family planning services, and to ameliorate the female sexual function during COVID-19 pandemic including consults with physicians, counsellors, and psychologists, as well as health education programs, either in person or virtually via telemedicine. (Afr J Reprod Health 2022;26[9]: 64-75). © 2022, Women's Health and Action Research Centre. All rights reserved.
ABSTRACT
This study described the maternal and perinatal outcomes of pregnant women infected with COVID-19. A cross-sectional descriptive design was used in this study of 75 women diagnosed with COVID-19 in the isolation unit of Obstetrics and Gynecology Department at Suez Canal University hospital. Data was collected by a structured interview questionnaire and assessment of patients' records in the period from April 26, 2021, to October 31, 2021. This study found that 7/29 (24.14%) of women had abortions, 9/46 (19.57%) had preterm labor, 2/19 (10.53%) had both postpartum hemorrhage and puerperal pyrexia, 2/46 (4.35%) had an antepartum hemorrhage, and 2/52 (3.85%) had preeclampsia. Regarding fetal complications, 2/46 (4.35%) had intrauterine fetal distress, and 2/52 (3.85%) had a stillbirth. Concerning neonatal outcomes, 31.25% of cases needed NICU admission, 12.5% required mechanical ventilation and developed ARDS, 18.75% had low birth weight, and only 6.25% of all cases died. This study concluded that pregnant women with COVID-19 seem to have a high risk of abortion and preterm birth. Their neonates are at high risk of NICU admission and low birth weight.
ABSTRACT
Background: Aberrancy in monocytes account is customar-ily recognized in patients with COVID-19 strikingly in gravely affected patients, the exacting interrelation with detrimental consequences still in the gap. The study was carried out to found any significant monocyte level changes in COVID-19 and its relation to diagnostic usefulness and expectation of adverse outcomes. A sample of 100 patients was recruited into the analysis;all with diagnosis compatible with pneumonia underwent care inwards of Al-Hussein Hospital for isola-tion;50 participators with COVID-19 as cases and 50 participators with influenza A elected control. The diagnosis was suggested by clinical and radiological attributes and verified by polymerase chain reaction. Monocytes total and laboratory analysis of inflammatory indices and organ vitality were achieved for all participants. The mean age was 64.4, includ-ing 56 males and 44 females. 66% of cases were monocy-topenic, 34% were non-monocytopenic. 12% of control were monocytopenic while 88% were non-monocytopenic with significant difference (P value=0.001). Forty-five participants were critical while 55 were non-critical, 37 COVID-19, and eight controls were critical and admitted to the ICU. Forty-one participants died, 35 from the COVID-19 category and six from controls. 30 of COVID-19 who were critical in ICU were monocytopenic (all died), three were non-monocytic (only one died) and 4 had monocytosis (all died), 6 of control who were critical in ICU were monocytopenic (all died), 2 had normal count (all survived) and no one had monocyto-penia (Odd ratio=1.200). Deviation in monocyte count from the norm is a valuable discriminator for the diagnosis of CO-VID-19 and a suitable anticipator across all spectrums for its adverse consequences. © 2021, Venezuelan Society of Pharmacology and Clinical and Therapeutic Pharmacology. All rights reserved.
ABSTRACT
Background: eosinopenia is habitually encountered hematological parameter in patients with COVID 19,its precise relevance with diagnosis, seriousness, and detrimental terminal consequences in COVID 19 cases is ambiguous. Objectives: the study was implemented to construct a link between eosinopenia and COVID 19 concerning diagnostic usefulness, anticipation of deleterious ramifications, and lethality in COVID 19 cases. Materials and methods: A random sample of (100) patients with acute respiratory illness subjected to admission in medical department in Al-Hussein teaching hospital were incorporated in the analysis,(50) cases with COVID-19 pneumonia and (50) control with influenza A pneumonia, both accused by clinical and radiological attributes and verified by Polymerase chain reaction. Eosinophil total, laboratory analysis of inflammatory indices and organ function was accomplished for the sum total of cases and controls. Results: mean age is (63.8400), (53) males and(47) females,(52) of entire sample were eosinopenic,(48) were non-eosinopenic,(46) of eosinopenic patient belong to COVID-19 category but just (6) belong to control category with significant difference (p value=0.001).(27) patients from COVID-19 category elected to be transferred to ICU services, concurrently just(5) patients from control category seek ICU service,(26) patient from COVID-19 category who were admitted to ICU are eosinopenic meanwhile just one in control category was eosinopenic(odd ratio:1.053).(26) patients of COVID-19 category died meanwhile (5) patients from control category died,(25) patients who died in COVID-19 category were eosinopenic meanwhile just one in control category was eosinopenic(Odd ratio:1.565). Conclusion: admission eosinopenia is a dependably applicable, easily intelligible test for prompt anticipation of diagnosis as well as unfavorable consequences of COVID 19. © 2020 Ubiquity Press. All rights reserved.